Clinical trial Iteos- A2A-004
A Multicenter, Open-Label, Phase I Clinical Study to assess the Safety, Tolerability, Pharmacokinetics and Food-Effect of Inupadenant New Formulation in Participants with Advanced Solid Tumors (Iteos- A2A-004)
| Organ | Multiple |
|---|---|
| Trial status | Trial closed |
| Investigator | |
| Trial type |
Interventional with experimental drug
|
| Phase | Trial phase 1 |
| Academic trial | Non |
| Sponsor | iTeos |
| EudraCT Identifier | 2020-005861-15 |
| ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT05117177 |
| Last update |